PUBLICATIONS · 12743142
Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2003 May 15
- First author
- Roach M 3rd
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2003 May 15;21(10):1899-901. doi: 10.1200/JCO.2003.01.129.
- note
- Source null
- related pmid
- 12743140
- relationship
- Comment in
- citation
- J Clin Oncol. 2004 Jun 1;22(11):2254-5; author reply 2255-7. doi: 10.1200/JCO.2004.99.218.
- note
- Source null
- related pmid
- 15169820
- relationship
- Comment in
Authors and identifiers
- name
- Roach M 3rd
- type
- Author
- name
- DeSilvio M
- type
- Author
- name
- Lawton C
- type
- Author
- name
- Uhl V
- type
- Author
- name
- Machtay M
- type
- Author
- name
- Seider MJ
- type
- Author
- name
- Rotman M
- type
- Author
- name
- Jones C
- type
- Author
- name
- Asbell SO
- type
- Author
- name
- Valicenti RK
- type
- Author
- name
- Han S
- type
- Author
- name
- Thomas CR Jr
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Roach M 3rd
- type
- Author
- name
- DeSilvio M
- type
- Author
- name
- Lawton C
- type
- Author
- name
- Uhl V
- type
- Author
- name
- Machtay M
- type
- Author
- name
- Seider MJ
- type
- Author
- name
- Rotman M
- type
- Author
- name
- Jones C
- type
- Author
- name
- Asbell SO
- type
- Author
- name
- Valicenti RK
- type
- Author
- name
- Han S
- type
- Author
- name
- Thomas CR Jr
- type
- Author
- bibliography ids
- nci-bib-296eaa58596e7ea9aa681cb1
- book metadata
- content sha256
- df68d57a8e3b300d3aae1af5465c026fcfe26eb3e5cfc39db987c2df280851a5
- document type
- citation
- dois
- 10.1200/JCO.2003.05.004
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:12743142
- immutable id
- pubmed:12743142@df68d57a8e3b300d3aae1af5465c026fcfe26eb3e5cfc39db987c2df280851a5
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- Source null
- issn print
- 0732-183X
- issue
- 10
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1904-11
- volume
- 21
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2003 May 15;21(10):1899-901. doi: 10.1200/JCO.2003.01.129.
- note
- Source null
- related pmid
- 12743140
- relationship
- Comment in
- citation
- J Clin Oncol. 2004 Jun 1;22(11):2254-5; author reply 2255-7. doi: 10.1200/JCO.2004.99.218.
- note
- Source null
- related pmid
- 15169820
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 12743142
- provenance
- batch id
- 2d0158fe73b50bb1a4bf
- provider
- NCBI PubMed ESummary
- record sha256
- dab093d4e8cfacb8a248cd6769417e1d054f7861195fffcc4be45739510e05d7
- response sha256
- d46de44782d91ef4394e88a69f82b1ee22148e8c4cf1534eb36c80479345e70e
- retrieved at
- 2026-09-09T23:45:50.935339+00:00
- publication date
- display
- 2003 May 15
- precision
- day
- year
- 2003
- publication types
- Clinical Trial
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413.
Preserved source evidence · Not medical advice
Triangle